Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Quantana - Quantification of gene editing in a precise, simple and affordable way

Reference number
Coordinator Countagen AB - Science for Life Laboratory
Funding from Vinnova SEK 300 000
Project duration April 2021 - October 2021
Status Completed
Venture Innovative Startups
Call Innovative Startups step 1 spring 2021

Important results from the project

We divided the project into 4 main achievement goals: i) Identification and mapping the needs and pains of the gene editing field, more specifically CRISPR/Cas9 researchers and validated product/market fit through customer interviews. ii) Identification of KOLs, created a database of potential customers and developed a go-to-market strategy. iii) Development of a prototype product for gene editing efficiency screening as well as filed two further patent applications. iv) Enrollment of test customers for a pilot study and already validated the assay in-house with test samples.

Expected long term effects

The successful outcome of the project is a strong business case around gene editing and the generation of a proof-of-concept that increased our attractiveness for further financing. Aim (i) and (ii) led to a clear understanding and confirmation of the market, which includes customer needs, competitors and scale up opportunities. Aim (iii) and (iv) resulted in a prototype product that has been validated in-house using test customer samples. Furthermore, these aims resulted in the generation of new IP, thereby further strengthening our business case and Countagen.

Approach and implementation

We are continuing the R&D activities towards finishing the external pilot test customer study with our developed prototype reagent kit and quantification chip. The generated data will be used as pre-liminary marketing material to enroll further test customers during Q1 ´22. Based on this activity, we will iterate our prototype product towards a potential product launch by Q3 ´22. This activity will be supported by consultants to set up a QC and the marketing campaign. Other aims are to develop a low-cost reader to capture other market segments as well as a high-throughput assay version.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 17 May 2022

Reference number 2021-00367